Trial Site Detail

 

Drug:
ARQ 092
Trial:
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Virginia Piper Cancer Center

10460 N. 92nd St.     
Scottsdale , AZ 85258
USA

 

Principal Investigator:
Contact:
Patient Care Coordinator at 480-323-1339 (toll free: 1-877-273-3713), or e-mail clinicaltrials@shc.org.
Activation Status of this Site:
Closed
Notes about this Site:
Virginia Piper Cancer Center Website:
http://www.shc.org/Medical+Services/Cancer+Care/Cancer+Care

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.